Senshu Nonaka1, Hidenori Oishi2, Satoshi Tsutsumi3, Kohsuke Teranishi4, Shunsuke Tanoue5, Yukimasa Yasumoto3, Munetaka Yamamoto4, Hajime Arai4. 1. Department of Neurosurgery, Juntendo University Urayasu Hospital, Urayasu, Japan. Electronic address: snonaka@juntendo.ac.jp. 2. Department of Neurosurgery, Juntendo University School of Medicine, Urayasu, Japan; Department of Neuroendovascular Therapy, Juntendo University School of Medicine, Urayasu, Japan. 3. Department of Neurosurgery, Juntendo University Urayasu Hospital, Urayasu, Japan. 4. Department of Neurosurgery, Juntendo University School of Medicine, Urayasu, Japan. 5. Department of Neuroendovascular Therapy, Juntendo University School of Medicine, Urayasu, Japan.
Abstract
BACKGROUND: Infectious intracranial aneurysms (IIAs) are rare but can cause substantial morbidity and mortality. We aimed to re-evaluate the role of endovascular therapy for the treatment of IIAs. METHODS: This study is a retrospective review of patients diagnosed with IIAs and treated by endovascular therapy in our institutions over the past 13 years. RESULTS: Four patients were diagnosed with infectious endocarditis with a total of 5 IIAs. Three of the 4 patients had ruptured IIAs. Two presented with intracerebral hemorrhage, one with subarachnoid hemorrhage, and one with cerebral infarction. The distal middle cerebral artery (MCA) was the most common site, followed by the distal segment of the posterior cerebral artery. Three patients were treated by parent artery occlusion and one by direct aneurysm obliteration. There were no periprocedural complications. One IIA treated by direct aneurysm occlusion was recanalized within 1 year and required a second embolization. Outcomes were measured by the modified Rankin Scale on discharge: 2 patients scored 0, 1 patient scored 1, and 1 patient scored 3. CONCLUSION: IIAs located deep in the brain or on the peripheral MCA can be safely treated with endovascular therapy even when they are lying in the eloquent cortex.
BACKGROUND: Infectious intracranial aneurysms (IIAs) are rare but can cause substantial morbidity and mortality. We aimed to re-evaluate the role of endovascular therapy for the treatment of IIAs. METHODS: This study is a retrospective review of patients diagnosed with IIAs and treated by endovascular therapy in our institutions over the past 13 years. RESULTS: Four patients were diagnosed with infectious endocarditis with a total of 5 IIAs. Three of the 4 patients had ruptured IIAs. Two presented with intracerebral hemorrhage, one with subarachnoid hemorrhage, and one with cerebral infarction. The distal middle cerebral artery (MCA) was the most common site, followed by the distal segment of the posterior cerebral artery. Three patients were treated by parent artery occlusion and one by direct aneurysm obliteration. There were no periprocedural complications. One IIA treated by direct aneurysm occlusion was recanalized within 1 year and required a second embolization. Outcomes were measured by the modified Rankin Scale on discharge: 2 patients scored 0, 1 patient scored 1, and 1 patient scored 3. CONCLUSION: IIAs located deep in the brain or on the peripheral MCA can be safely treated with endovascular therapy even when they are lying in the eloquent cortex.